Brandon Young speaks to ecancer at the WIN 2019 Symposium in Paris about how the integration of DNA and RNA investigations in clinical trials.
He gives background and findings from the triple combination SPRING trial for patients with non-small cell lung cancer.
He explains that there are six different triple combinations that they are interested in studying and that they would like to use the Sims algorithm in order to utilise the full expression profile.